Report Detail
COVID-19 Impact on Global Over The Counter (OTC) Drugs Market Insights, Forecast to 2026
- RnM4042279 |
- 15 June, 2020 |
- Global |
- 115 Pages |
- QYResearch |
- Pharma & Healthcare
Over The Counter (OTC) Drugs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Over The Counter (OTC) Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Over The Counter (OTC) Drugs market is segmented into
Analgesics
Dermatology Products
Gastrointestinal Products
Vitamins, Mineral, and Supplements (VMS)
Weight Loss/Dietary Products
Ophthalmic Products
Sleeping Aids
Others
Segment by Application, the Over The Counter (OTC) Drugs market is segmented into
Hospital Pharmacies
Retail Pharmacies
Online Pharmacy
Others
Regional and Country-level Analysis
The Over The Counter (OTC) Drugs market is analysed and market size information is provided by regions (countries).
The key regions covered in the Over The Counter (OTC) Drugs market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Over The Counter (OTC) Drugs Market Share Analysis
Over The Counter (OTC) Drugs market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Over The Counter (OTC) Drugs business, the date to enter into the Over The Counter (OTC) Drugs market, Over The Counter (OTC) Drugs product introduction, recent developments, etc.
The major vendors covered:
Bayer AG
Boehringer Ingelheim
GlaxoSmithKline PLC
Johnson & Johnson
Novartis International AG
Pfizer,Inc.
PGT healthcare
Sanofi S.A
Takeda
1 Study Coverage
- 1.1 Over The Counter (OTC) Drugs Product Introduction
- 1.2 Market Segments
- 1.3 Key Over The Counter (OTC) Drugs Manufacturers Covered: Ranking by Revenue
- 1.4 Market by Type
- 1.4.1 Global Over The Counter (OTC) Drugs Market Size Growth Rate by Type
- 1.4.2 Analgesics
- 1.4.3 Dermatology Products
- 1.4.4 Gastrointestinal Products
- 1.4.5 Vitamins, Mineral, and Supplements (VMS)
- 1.4.6 Weight Loss/Dietary Products
- 1.4.7 Ophthalmic Products
- 1.4.8 Sleeping Aids
- 1.4.9 Others
- 1.5 Market by Application
- 1.5.1 Global Over The Counter (OTC) Drugs Market Size Growth Rate by Application
- 1.5.2 Hospital Pharmacies
- 1.5.3 Retail Pharmacies
- 1.5.4 Online Pharmacy
- 1.5.5 Others
- 1.6 Coronavirus Disease 2019 (Covid-19): Over The Counter (OTC) Drugs Industry Impact
- 1.6.1 How the Covid-19 is Affecting the Over The Counter (OTC) Drugs Industry
- 1.6.1.1 Over The Counter (OTC) Drugs Business Impact Assessment - Covid-19
- 1.6.1.2 Supply Chain Challenges
- 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
- 1.6.2 Market Trends and Over The Counter (OTC) Drugs Potential Opportunities in the COVID-19 Landscape
- 1.6.3 Measures / Proposal against Covid-19
- 1.6.3.1 Government Measures to Combat Covid-19 Impact
- 1.6.3.2 Proposal for Over The Counter (OTC) Drugs Players to Combat Covid-19 Impact
- 1.6.1 How the Covid-19 is Affecting the Over The Counter (OTC) Drugs Industry
- 1.7 Study Objectives
- 1.8 Years Considered
2 Executive Summary
- 2.1 Global Over The Counter (OTC) Drugs Market Size Estimates and Forecasts
- 2.1.1 Global Over The Counter (OTC) Drugs Revenue 2015-2026
- 2.1.2 Global Over The Counter (OTC) Drugs Sales 2015-2026
- 2.2 Over The Counter (OTC) Drugs Market Size by Region: 2020 Versus 2026
- 2.2.1 Global Over The Counter (OTC) Drugs Retrospective Market Scenario in Sales by Region: 2015-2020
- 2.2.2 Global Over The Counter (OTC) Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Over The Counter (OTC) Drugs Competitor Landscape by Players
- 3.1 Over The Counter (OTC) Drugs Sales by Manufacturers
- 3.1.1 Over The Counter (OTC) Drugs Sales by Manufacturers (2015-2020)
- 3.1.2 Over The Counter (OTC) Drugs Sales Market Share by Manufacturers (2015-2020)
- 3.2 Over The Counter (OTC) Drugs Revenue by Manufacturers
- 3.2.1 Over The Counter (OTC) Drugs Revenue by Manufacturers (2015-2020)
- 3.2.2 Over The Counter (OTC) Drugs Revenue Share by Manufacturers (2015-2020)
- 3.2.3 Global Over The Counter (OTC) Drugs Market Concentration Ratio (CR5 and HHI) (2015-2020)
- 3.2.4 Global Top 10 and Top 5 Companies by Over The Counter (OTC) Drugs Revenue in 2019
- 3.2.5 Global Over The Counter (OTC) Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
- 3.3 Over The Counter (OTC) Drugs Price by Manufacturers
- 3.4 Over The Counter (OTC) Drugs Manufacturing Base Distribution, Product Types
- 3.4.1 Over The Counter (OTC) Drugs Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Over The Counter (OTC) Drugs Product Type
- 3.4.3 Date of International Manufacturers Enter into Over The Counter (OTC) Drugs Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
- 4.1 Global Over The Counter (OTC) Drugs Market Size by Type (2015-2020)
- 4.1.1 Global Over The Counter (OTC) Drugs Sales by Type (2015-2020)
- 4.1.2 Global Over The Counter (OTC) Drugs Revenue by Type (2015-2020)
- 4.1.3 Over The Counter (OTC) Drugs Average Selling Price (ASP) by Type (2015-2026)
- 4.2 Global Over The Counter (OTC) Drugs Market Size Forecast by Type (2021-2026)
- 4.2.1 Global Over The Counter (OTC) Drugs Sales Forecast by Type (2021-2026)
- 4.2.2 Global Over The Counter (OTC) Drugs Revenue Forecast by Type (2021-2026)
- 4.2.3 Over The Counter (OTC) Drugs Average Selling Price (ASP) Forecast by Type (2021-2026)
- 4.3 Global Over The Counter (OTC) Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Breakdown Data by Application (2015-2026)
- 5.1 Global Over The Counter (OTC) Drugs Market Size by Application (2015-2020)
- 5.1.1 Global Over The Counter (OTC) Drugs Sales by Application (2015-2020)
- 5.1.2 Global Over The Counter (OTC) Drugs Revenue by Application (2015-2020)
- 5.1.3 Over The Counter (OTC) Drugs Price by Application (2015-2020)
- 5.2 Over The Counter (OTC) Drugs Market Size Forecast by Application (2021-2026)
- 5.2.1 Global Over The Counter (OTC) Drugs Sales Forecast by Application (2021-2026)
- 5.2.2 Global Over The Counter (OTC) Drugs Revenue Forecast by Application (2021-2026)
- 5.2.3 Global Over The Counter (OTC) Drugs Price Forecast by Application (2021-2026)
6 North America
- 6.1 North America Over The Counter (OTC) Drugs by Country
- 6.1.1 North America Over The Counter (OTC) Drugs Sales by Country
- 6.1.2 North America Over The Counter (OTC) Drugs Revenue by Country
- 6.1.3 U.S.
- 6.1.4 Canada
- 6.2 North America Over The Counter (OTC) Drugs Market Facts & Figures by Type
- 6.3 North America Over The Counter (OTC) Drugs Market Facts & Figures by Application
7 Europe
- 7.1 Europe Over The Counter (OTC) Drugs by Country
- 7.1.1 Europe Over The Counter (OTC) Drugs Sales by Country
- 7.1.2 Europe Over The Counter (OTC) Drugs Revenue by Country
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 U.K.
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Over The Counter (OTC) Drugs Market Facts & Figures by Type
- 7.3 Europe Over The Counter (OTC) Drugs Market Facts & Figures by Application
8 Asia Pacific
- 8.1 Asia Pacific Over The Counter (OTC) Drugs by Region
- 8.1.1 Asia Pacific Over The Counter (OTC) Drugs Sales by Region
- 8.1.2 Asia Pacific Over The Counter (OTC) Drugs Revenue by Region
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 South Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Taiwan
- 8.1.9 Indonesia
- 8.1.10 Thailand
- 8.1.11 Malaysia
- 8.1.12 Philippines
- 8.1.13 Vietnam
- 8.2 Asia Pacific Over The Counter (OTC) Drugs Market Facts & Figures by Type
- 8.3 Asia Pacific Over The Counter (OTC) Drugs Market Facts & Figures by Application
9 Latin America
- 9.1 Latin America Over The Counter (OTC) Drugs by Country
- 9.1.1 Latin America Over The Counter (OTC) Drugs Sales by Country
- 9.1.2 Latin America Over The Counter (OTC) Drugs Revenue by Country
- 9.1.3 Mexico
- 9.1.4 Brazil
- 9.1.5 Argentina
- 9.2 Central & South America Over The Counter (OTC) Drugs Market Facts & Figures by Type
- 9.3 Central & South America Over The Counter (OTC) Drugs Market Facts & Figures by Application
10 Middle East and Africa
- 10.1 Middle East and Africa Over The Counter (OTC) Drugs by Country
- 10.1.1 Middle East and Africa Over The Counter (OTC) Drugs Sales by Country
- 10.1.2 Middle East and Africa Over The Counter (OTC) Drugs Revenue by Country
- 10.1.3 Turkey
- 10.1.4 Saudi Arabia
- 10.1.5 U.A.E
- 10.2 Middle East and Africa Over The Counter (OTC) Drugs Market Facts & Figures by Type
- 10.3 Middle East and Africa Over The Counter (OTC) Drugs Market Facts & Figures by Application
11 Company Profiles
- 11.1 Bayer AG
- 11.1.1 Bayer AG Corporation Information
- 11.1.2 Bayer AG Description, Business Overview and Total Revenue
- 11.1.3 Bayer AG Sales, Revenue and Gross Margin (2015-2020)
- 11.1.4 Bayer AG Over The Counter (OTC) Drugs Products Offered
- 11.1.5 Bayer AG Recent Development
- 11.2 Boehringer Ingelheim
- 11.2.1 Boehringer Ingelheim Corporation Information
- 11.2.2 Boehringer Ingelheim Description, Business Overview and Total Revenue
- 11.2.3 Boehringer Ingelheim Sales, Revenue and Gross Margin (2015-2020)
- 11.2.4 Boehringer Ingelheim Over The Counter (OTC) Drugs Products Offered
- 11.2.5 Boehringer Ingelheim Recent Development
- 11.3 GlaxoSmithKline PLC
- 11.3.1 GlaxoSmithKline PLC Corporation Information
- 11.3.2 GlaxoSmithKline PLC Description, Business Overview and Total Revenue
- 11.3.3 GlaxoSmithKline PLC Sales, Revenue and Gross Margin (2015-2020)
- 11.3.4 GlaxoSmithKline PLC Over The Counter (OTC) Drugs Products Offered
- 11.3.5 GlaxoSmithKline PLC Recent Development
- 11.4 Johnson & Johnson
- 11.4.1 Johnson & Johnson Corporation Information
- 11.4.2 Johnson & Johnson Description, Business Overview and Total Revenue
- 11.4.3 Johnson & Johnson Sales, Revenue and Gross Margin (2015-2020)
- 11.4.4 Johnson & Johnson Over The Counter (OTC) Drugs Products Offered
- 11.4.5 Johnson & Johnson Recent Development
- 11.5 Novartis International AG
- 11.5.1 Novartis International AG Corporation Information
- 11.5.2 Novartis International AG Description, Business Overview and Total Revenue
- 11.5.3 Novartis International AG Sales, Revenue and Gross Margin (2015-2020)
- 11.5.4 Novartis International AG Over The Counter (OTC) Drugs Products Offered
- 11.5.5 Novartis International AG Recent Development
- 11.6 Pfizer,Inc.
- 11.6.1 Pfizer,Inc. Corporation Information
- 11.6.2 Pfizer,Inc. Description, Business Overview and Total Revenue
- 11.6.3 Pfizer,Inc. Sales, Revenue and Gross Margin (2015-2020)
- 11.6.4 Pfizer,Inc. Over The Counter (OTC) Drugs Products Offered
- 11.6.5 Pfizer,Inc. Recent Development
- 11.7 PGT healthcare
- 11.7.1 PGT healthcare Corporation Information
- 11.7.2 PGT healthcare Description, Business Overview and Total Revenue
- 11.7.3 PGT healthcare Sales, Revenue and Gross Margin (2015-2020)
- 11.7.4 PGT healthcare Over The Counter (OTC) Drugs Products Offered
- 11.7.5 PGT healthcare Recent Development
- 11.8 Sanofi S.A
- 11.8.1 Sanofi S.A Corporation Information
- 11.8.2 Sanofi S.A Description, Business Overview and Total Revenue
- 11.8.3 Sanofi S.A Sales, Revenue and Gross Margin (2015-2020)
- 11.8.4 Sanofi S.A Over The Counter (OTC) Drugs Products Offered
- 11.8.5 Sanofi S.A Recent Development
- 11.9 Takeda
- 11.9.1 Takeda Corporation Information
- 11.9.2 Takeda Description, Business Overview and Total Revenue
- 11.9.3 Takeda Sales, Revenue and Gross Margin (2015-2020)
- 11.9.4 Takeda Over The Counter (OTC) Drugs Products Offered
- 11.9.5 Takeda Recent Development
- 11.1 Bayer AG
- 11.1.1 Bayer AG Corporation Information
- 11.1.2 Bayer AG Description, Business Overview and Total Revenue
- 11.1.3 Bayer AG Sales, Revenue and Gross Margin (2015-2020)
- 11.1.4 Bayer AG Over The Counter (OTC) Drugs Products Offered
- 11.1.5 Bayer AG Recent Development
12 Future Forecast by Regions (Countries) (2021-2026)
- 12.1 Over The Counter (OTC) Drugs Market Estimates and Projections by Region
- 12.1.1 Global Over The Counter (OTC) Drugs Sales Forecast by Regions 2021-2026
- 12.1.2 Global Over The Counter (OTC) Drugs Revenue Forecast by Regions 2021-2026
- 12.2 North America Over The Counter (OTC) Drugs Market Size Forecast (2021-2026)
- 12.2.1 North America: Over The Counter (OTC) Drugs Sales Forecast (2021-2026)
- 12.2.2 North America: Over The Counter (OTC) Drugs Revenue Forecast (2021-2026)
- 12.2.3 North America: Over The Counter (OTC) Drugs Market Size Forecast by Country (2021-2026)
- 12.3 Europe Over The Counter (OTC) Drugs Market Size Forecast (2021-2026)
- 12.3.1 Europe: Over The Counter (OTC) Drugs Sales Forecast (2021-2026)
- 12.3.2 Europe: Over The Counter (OTC) Drugs Revenue Forecast (2021-2026)
- 12.3.3 Europe: Over The Counter (OTC) Drugs Market Size Forecast by Country (2021-2026)
- 12.4 Asia Pacific Over The Counter (OTC) Drugs Market Size Forecast (2021-2026)
- 12.4.1 Asia Pacific: Over The Counter (OTC) Drugs Sales Forecast (2021-2026)
- 12.4.2 Asia Pacific: Over The Counter (OTC) Drugs Revenue Forecast (2021-2026)
- 12.4.3 Asia Pacific: Over The Counter (OTC) Drugs Market Size Forecast by Region (2021-2026)
- 12.5 Latin America Over The Counter (OTC) Drugs Market Size Forecast (2021-2026)
- 12.5.1 Latin America: Over The Counter (OTC) Drugs Sales Forecast (2021-2026)
- 12.5.2 Latin America: Over The Counter (OTC) Drugs Revenue Forecast (2021-2026)
- 12.5.3 Latin America: Over The Counter (OTC) Drugs Market Size Forecast by Country (2021-2026)
- 12.6 Middle East and Africa Over The Counter (OTC) Drugs Market Size Forecast (2021-2026)
- 12.6.1 Middle East and Africa: Over The Counter (OTC) Drugs Sales Forecast (2021-2026)
- 12.6.2 Middle East and Africa: Over The Counter (OTC) Drugs Revenue Forecast (2021-2026)
- 12.6.3 Middle East and Africa: Over The Counter (OTC) Drugs Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Porter’s Five Forces Analysis
- 13.5 Primary Interviews with Key Over The Counter (OTC) Drugs Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Over The Counter (OTC) Drugs Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
Summary:
Get latest Market Research Reports on COVID-19 Impact on Global Over The Counter (OTC) Drugs. Industry analysis & Market Report on COVID-19 Impact on Global Over The Counter (OTC) Drugs is a syndicated market report, published as COVID-19 Impact on Global Over The Counter (OTC) Drugs Market Insights, Forecast to 2026. It is complete Research Study and Industry Analysis of COVID-19 Impact on Global Over The Counter (OTC) Drugs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
